Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors

Anna Orlova, Fredrik Y. Nilsson, Maria Wikman, Charles Widström, Stefan Ståhl, Jörgen Carlsson and Vladimir Tolmachev
Journal of Nuclear Medicine March 2006, 47 (3) 512-519;
Anna Orlova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Y. Nilsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Wikman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Widström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Ståhl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jörgen Carlsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Tolmachev
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 47 no. 3 512-519
PubMed 
16513621

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 12, 2005
  • Accepted for publication November 14, 2005
  • Published online March 1, 2006.

Copyright & Usage 
© 2006 by Society of Nuclear Medicine

Author Information

  1. Anna Orlova, PhD 1 , 2 ,
  2. Fredrik Y. Nilsson, PhD 1 , 2 ,
  3. Maria Wikman, PhD 3 ,
  4. Charles Widström, MSc 4 ,
  5. Stefan Ståhl, PhD 3 ,
  6. Jörgen Carlsson, PhD 2 and
  7. Vladimir Tolmachev, PhD 1 , 2
  1. 1Affibody AB, Bromma, Sweden; 2Unit of Biomedical Radiation Sciences, Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; 3Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology (KTH), Stockholm, Sweden; and 4Section of Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden
  1. For correspondence or reprints contact: Vladimir Tolmachev, PhD, Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, 751 85 Uppsala, Sweden. E-mail: valdimir.tolmachev{at}bms.uu.se
View Full Text

Statistics from Altmetric.com

Cited By...

  • 86 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2006 to February 2023

AbstractFullPdf
Mar 200611651106
Apr 2006202628
May 2006164437
Jun 2006161822
Jul 200692015
Aug 200692523
Sep 2006181621
Oct 2006231717
Nov 2006162118
Dec 200613107
Jan 2007101714
Feb 2007879
Mar 200734325
Apr 200783623
May 200773726
Jun 200763220
Jul 200734220
Aug 20076235
Sep 200733720
Oct 2007122714
Nov 200772713
Dec 200762814
Jan 2008132519
Feb 2008134518
Mar 2008153419
Apr 2008155027
May 2008124323
Jun 200852814
Jul 2008172518
Aug 2008342610
Sep 2008593016
Oct 2008342519
Nov 2008103211
Dec 200892916
Jan 200982211
Feb 2009103316
Mar 2009153119
Apr 200991611
May 20096116
Jun 2009113410
Jul 2009104417
Aug 20098185
Sep 20096194
Oct 200963613
Nov 20099248
Dec 2009122311
Jan 2010161214
Feb 2010193514
Mar 2010202118
Apr 2010102110
May 201073017
Jun 20108914
Jul 201031156
Aug 201040139
Sep 20101396
Oct 201072810
Nov 201012249
Dec 2010141410
Jan 2011133712
Feb 201161911
Mar 201183116
Apr 2011101716
May 201191718
Jun 2011111812
Jul 2011251311
Aug 2011131418
Sep 2011303220
Oct 201132249
Nov 2011222511
Dec 201117196
Jan 2012252118
Feb 2012181713
Mar 2012401815
Apr 201253159
May 2012292012
Jun 2012291611
Jul 2012371415
Aug 2012181111
Sep 2012482514
Oct 2012311819
Nov 2012482013
Dec 201240165
Jan 2013232424
Feb 2013182410
Mar 2013211814
Apr 2013321713
May 2013341712
Jun 2013211011
Jul 20132887
Aug 201321104
Sep 201321125
Oct 201319147
Nov 2013181510
Dec 20138505
Jan 201413256
Feb 2014132216
Mar 201414710
Apr 201421913
May 2014111312
Jun 201491014
Jul 201415411
Aug 20146497
Sep 201417813
Oct 201420813
Nov 20149921
Dec 201411811
Jan 201515119
Feb 2015121415
Mar 201538118
Apr 20151195
May 20151987
Jun 20151395
Jul 2015121013
Aug 20151683
Sep 201515167
Oct 2015777
Nov 201529246
Dec 20151661114
Jan 201623127
Feb 20161646
Mar 201627716
Apr 201626414
May 201612612
Jun 20161374
Jul 201617411
Aug 20166212
Sep 20162177
Oct 2016221910
Nov 201624216
Dec 2016466
Jan 201715615
Feb 2017745
Mar 20176510
Apr 20171243
May 2017303
Jun 2017654
Jul 2017870
Aug 20175412
Sep 2017478
Oct 2017441
Nov 2017543
Dec 20174106
Jan 2018289
Feb 2018333
Mar 2018434
Apr 2018653
May 20186119
Jun 2018271
Jul 2018232
Aug 20181555
Sep 2018742
Oct 20181892
Nov 20189716
Dec 2018386
Jan 2019956
Feb 2019996
Mar 2019963
Apr 20193116
May 2019958
Jun 2019459
Jul 20196511
Aug 2019875
Sep 2019377
Oct 2019136
Nov 20191043
Dec 20196612
Jan 20201658
Feb 20201454
Mar 2020734
Apr 2020375
May 2020244
Jun 2020556
Jul 2020212
Aug 2020225
Sep 2020793
Oct 20201526
Nov 2020523
Dec 20206102
Jan 20214167
Feb 202151911
Mar 20213184
Apr 2021142
May 20211113
Jun 20215101
Jul 2021397
Aug 20213112
Sep 20213195
Oct 20212206
Nov 202111012
Dec 202110713
Jan 2022555
Feb 2022475
Mar 20220102
Apr 20222144
May 20223136
Jun 2022162
Jul 2022243
Aug 2022245
Sep 20222105
Oct 20223164
Nov 20225117
Dec 20224153
Jan 20232119
Feb 2023296
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (3)
Journal of Nuclear Medicine
Vol. 47, Issue 3
March 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors
Anna Orlova, Fredrik Y. Nilsson, Maria Wikman, Charles Widström, Stefan Ståhl, Jörgen Carlsson, Vladimir Tolmachev
Journal of Nuclear Medicine Mar 2006, 47 (3) 512-519;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparative In Vivo Evaluation of Technetium and Iodine Labels on an Anti-HER2 Affibody for Single-Photon Imaging of HER2 Expression in Tumors
Anna Orlova, Fredrik Y. Nilsson, Maria Wikman, Charles Widström, Stefan Ståhl, Jörgen Carlsson, Vladimir Tolmachev
Journal of Nuclear Medicine Mar 2006, 47 (3) 512-519;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
  • Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy
  • Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
  • Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
  • Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
  • A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
  • Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
  • Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
  • Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules
  • Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT
  • Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
  • Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire